Funding
Cancer
CANCER
This work was specifically supported by CRUK (C471/A19252) and the AsCaP collaboration (C569/A24991). The main trial is supported by grants from Cancer Research UK (C471/A15015), the National Institute for Health Research Health Technology Assessment Programme (12/01/38) and the MRC (MC_UU_00004/02 and MC_UU_12023/28). Bayer Pharmaceuticals AG provided aspirin and placebo, free of charge. 